Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Julia Lenore Marcus, Ph.D.

Concepts

This page shows the publications Julia Marcus has written about Humans.
Connection Strength

0.544
  1. Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program. N Engl J Med. 2022 06 02; 386(22):2064-2066.
    View in: PubMed
    Score: 0.011
  2. Making PrEP easy. Lancet HIV. 2022 04; 9(4):e226-e228.
    View in: PubMed
    Score: 0.011
  3. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S. AIDS Behav. 2022 Jul; 26(7):2212-2223.
    View in: PubMed
    Score: 0.011
  4. Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV. HIV Med. 2022 07; 23(6):620-628.
    View in: PubMed
    Score: 0.011
  5. Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e17-e21.
    View in: PubMed
    Score: 0.011
  6. HIV Preexposure Prophylaxis and Sexual Satisfaction Among Men Who Have Sex With Men. Sex Transm Dis. 2021 10 01; 48(10):e135-e137.
    View in: PubMed
    Score: 0.010
  7. Projected HIV and Bacterial Sexually Transmitted Infection Incidence Following COVID-19-Related Sexual Distancing and Clinical Service Interruption. J Infect Dis. 2021 03 29; 223(6):1019-1028.
    View in: PubMed
    Score: 0.010
  8. Prioritising pleasure and correcting misinformation in the era of U=U. Lancet HIV. 2021 03; 8(3):e175-e180.
    View in: PubMed
    Score: 0.010
  9. To Contact Tracing... and Beyond! Clin Infect Dis. 2021 02 16; 72(4):724-725.
    View in: PubMed
    Score: 0.010
  10. Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out. Clin Infect Dis. 2020 12 15; 71(12):3152-3153.
    View in: PubMed
    Score: 0.010
  11. Machine Learning for Human Immunodeficiency Virus Prevention in Rural Africa: The SEARCH for Sustainability. Clin Infect Dis. 2020 12 03; 71(9):2334-2335.
    View in: PubMed
    Score: 0.010
  12. Tenofovir Alafenamide for HIV Preexposure Prophylaxis. Ann Intern Med. 2020 07 07; 173(1):78.
    View in: PubMed
    Score: 0.010
  13. Nondaily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2020 06 01; 84(2):182-188.
    View in: PubMed
    Score: 0.010
  14. Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic. Curr HIV/AIDS Rep. 2020 06; 17(3):171-179.
    View in: PubMed
    Score: 0.010
  15. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020 06 01; 3(6):e207954.
    View in: PubMed
    Score: 0.010
  16. Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States. Clin Infect Dis. 2020 05 06; 70(10):2221-2223.
    View in: PubMed
    Score: 0.009
  17. Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value? Ann Intern Med. 2020 02 18; 172(4):281-282.
    View in: PubMed
    Score: 0.009
  18. Words Matter: Putting an End to "Unsafe" and "Risky" Sex. Sex Transm Dis. 2020 01; 47(1):1-3.
    View in: PubMed
    Score: 0.009
  19. Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know. Dermatol Clin. 2020 Apr; 38(2):233-238.
    View in: PubMed
    Score: 0.009
  20. Working Toward Broad and Equitable Access to HIV Preexposure Prophylaxis. Am J Public Health. 2019 09; 109(9):1160-1161.
    View in: PubMed
    Score: 0.009
  21. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study. Lancet HIV. 2019 10; 6(10):e688-e695.
    View in: PubMed
    Score: 0.009
  22. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Int J STD AIDS. 2019 06; 30(7):689-695.
    View in: PubMed
    Score: 0.009
  23. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017. Clin Gastroenterol Hepatol. 2020 02; 18(2):511-513.
    View in: PubMed
    Score: 0.009
  24. Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis. N Engl J Med. 2019 Feb 07; 380(6):510-512.
    View in: PubMed
    Score: 0.009
  25. Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections. AIDS Behav. 2019 Feb; 23(2):544-547.
    View in: PubMed
    Score: 0.009
  26. Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California. AIDS Care. 2019 05; 31(5):536-544.
    View in: PubMed
    Score: 0.009
  27. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med. 2019 01; 20(1):19-26.
    View in: PubMed
    Score: 0.008
  28. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States. Ann Epidemiol. 2018 12; 28(12):830-832.
    View in: PubMed
    Score: 0.008
  29. Potential Overestimation of Racial Disparities in Response to the 8-Week Ledipasvir/Sofosbuvir Regimen for Hepatitis C Virus Genotype 1 Infection. Gastroenterology. 2018 11; 155(5):1646-1647.e2.
    View in: PubMed
    Score: 0.008
  30. HIV Preexposure Prophylaxis as a Gateway to Primary Care. Am J Public Health. 2018 10; 108(10):1418-1420.
    View in: PubMed
    Score: 0.008
  31. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population. Public Health Rep. 2018 Jul/Aug; 133(4):452-460.
    View in: PubMed
    Score: 0.008
  32. Concerns about a study on sexually transmitted infections after initiation of HIV preexposure prophylaxis. AIDS. 2018 04 24; 32(7):955-956.
    View in: PubMed
    Score: 0.008
  33. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients. Clin Gastroenterol Hepatol. 2018 06; 16(6):927-935.
    View in: PubMed
    Score: 0.008
  34. HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis. AIDS Res Hum Retroviruses. 2018 04; 34(4):329-330.
    View in: PubMed
    Score: 0.008
  35. Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures. Clin Infect Dis. 2017 10 30; 65(10):1768-1769.
    View in: PubMed
    Score: 0.008
  36. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals. AIDS. 2017 04 24; 31(7):989-993.
    View in: PubMed
    Score: 0.008
  37. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):540-546.
    View in: PubMed
    Score: 0.007
  38. Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System. Am J Public Health. 2016 10; 106(10):e2-3.
    View in: PubMed
    Score: 0.007
  39. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS. 2016 10; 30(10):463-470.
    View in: PubMed
    Score: 0.007
  40. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):39-46.
    View in: PubMed
    Score: 0.007
  41. Preexposure Prophylaxis and Patient Centeredness: A Call for Holistically Protecting and Promoting the Health of Gay Men. Am J Mens Health. 2016 09; 10(5):353-8.
    View in: PubMed
    Score: 0.007
  42. Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):413-9.
    View in: PubMed
    Score: 0.007
  43. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep. 2016 Apr; 13(2):116-24.
    View in: PubMed
    Score: 0.007
  44. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. AIDS Patient Care STDS. 2015 Jul; 29(7):370-8.
    View in: PubMed
    Score: 0.007
  45. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
    View in: PubMed
    Score: 0.007
  46. HIV infection and incidence of ischemic stroke. AIDS. 2014 Aug 24; 28(13):1911-9.
    View in: PubMed
    Score: 0.006
  47. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View in: PubMed
    Score: 0.006
  48. Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men. PLoS One. 2014; 9(3):e91513.
    View in: PubMed
    Score: 0.006
  49. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions. HIV Med. 2014 Aug; 15(7):385-95.
    View in: PubMed
    Score: 0.006
  50. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013; 8(12):e81997.
    View in: PubMed
    Score: 0.006
  51. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sex Transm Dis. 2011 Oct; 38(10):922-4.
    View in: PubMed
    Score: 0.005
  52. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sex Transm Dis. 2011 May; 38(5):372-3.
    View in: PubMed
    Score: 0.005
  53. HCV infection as an emerging sexually transmitted disease. MLO Med Lab Obs. 2011 Apr; 43(4):52, 54-5.
    View in: PubMed
    Score: 0.005
  54. Syphilis testing behavior following diagnosis with early syphilis among men who have sex with men--San Francisco, 2005-2008. Sex Transm Dis. 2011 Jan; 38(1):24-9.
    View in: PubMed
    Score: 0.005
  55. Prediction model to maximize impact of syphilis partner notification--San Francisco, 2004-2008. Sex Transm Dis. 2010 Feb; 37(2):109-14.
    View in: PubMed
    Score: 0.005
  56. Sentinel surveillance of rectal chlamydia and gonorrhea among males--San Francisco, 2005-2008. Sex Transm Dis. 2010 Jan; 37(1):59-61.
    View in: PubMed
    Score: 0.005
  57. Evidence of underreporting of adverse childhood experiences, San Francisco municipal STD clinic, 2007. Sex Transm Dis. 2009 Jul; 36(7):422-4.
    View in: PubMed
    Score: 0.004
  58. Updated outcomes of partner notification for human immunodeficiency virus, San Francisco, 2004-2008. AIDS. 2009 May 15; 23(8):1024-6.
    View in: PubMed
    Score: 0.004
  59. What Has the Pandemic Revealed about the Shortcomings of Modern Epidemiology? What Can We Fix or Do Better? Am J Epidemiol. 2022 05 20; 191(6):980-986.
    View in: PubMed
    Score: 0.003
  60. Implementing expanded COVID-19 testing in Massachusetts community health centers through community partnerships: Protocol for an interrupted time series and stepped wedge study design. Contemp Clin Trials. 2022 07; 118:106783.
    View in: PubMed
    Score: 0.003
  61. HIV Pre-exposure Prophylaxis Continuum of Care Among Transgender Individuals in an Integrated Health care System. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):e30.
    View in: PubMed
    Score: 0.003
  62. Cannabis Use and Patient-Centered Care During Pregnancy and Post Partum Among People Living With HIV. JAMA Netw Open. 2021 12 01; 4(12):e2137588.
    View in: PubMed
    Score: 0.003
  63. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States. Clin Infect Dis. 2021 10 05; 73(7):e2261-e2269.
    View in: PubMed
    Score: 0.003
  64. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2188-2196.
    View in: PubMed
    Score: 0.003
  65. Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care. J Acquir Immune Defic Syndr. 2021 09 01; 88(1):31-35.
    View in: PubMed
    Score: 0.003
  66. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. JAMA Netw Open. 2021 08 02; 4(8):e2122692.
    View in: PubMed
    Score: 0.003
  67. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy. Clin Infect Dis. 2021 07 30; 73(Suppl 2):S170-S176.
    View in: PubMed
    Score: 0.003
  68. A decision analytics model to optimize investment in interventions targeting the HIV preexposure prophylaxis cascade of care. AIDS. 2021 07 15; 35(9):1479-1489.
    View in: PubMed
    Score: 0.003
  69. Perceived Interruptions to HIV Prevention and Treatment Services Associated With COVID-19 for Gay, Bisexual, and Other Men Who Have Sex With Men in 20 Countries. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):644-651.
    View in: PubMed
    Score: 0.003
  70. Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):663-670.
    View in: PubMed
    Score: 0.003
  71. Patient-Led Decision-Making for HIV Preexposure Prophylaxis. Curr HIV/AIDS Rep. 2021 02; 18(1):48-56.
    View in: PubMed
    Score: 0.002
  72. Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco. Clin Infect Dis. 2020 12 17; 71(10):2710-2712.
    View in: PubMed
    Score: 0.002
  73. More Screening or More Disease? Gonorrhea Testing and Positivity Patterns Among Men in 3 Large Clinical Practices in Massachusetts, 2010-2017. Clin Infect Dis. 2020 12 03; 71(9):e399-e405.
    View in: PubMed
    Score: 0.002
  74. Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework. AIDS Educ Prev. 2020 10; 32(5):392-402.
    View in: PubMed
    Score: 0.002
  75. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Transm Infect. 2020 05; 96(3):184-188.
    View in: PubMed
    Score: 0.002
  76. Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers. AIDS Patient Care STDS. 2019 08; 33(8):372-378.
    View in: PubMed
    Score: 0.002
  77. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019 02; 22(2):e25250.
    View in: PubMed
    Score: 0.002
  78. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population. Clin Infect Dis. 2019 01 07; 68(2):213-221.
    View in: PubMed
    Score: 0.002
  79. Screening Peter to Save Paul: The Population-Level Effects of Screening Men Who Have Sex With Men for Gonorrhea and Chlamydia. Sex Transm Dis. 2018 09; 45(9):623-625.
    View in: PubMed
    Score: 0.002
  80. Kiss and Tell: Limited Empirical Data on Oropharyngeal Neisseria gonorrhoeae Among Men Who Have Sex With Men and Implications for Modeling. Sex Transm Dis. 2017 10; 44(10):596-598.
    View in: PubMed
    Score: 0.002
  81. Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study. Prev Sci. 2017 08; 18(6):737-747.
    View in: PubMed
    Score: 0.002
  82. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015 Nov 15; 61(10):1601-3.
    View in: PubMed
    Score: 0.002
  83. Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015 Jun 01; 60(11):1728-9.
    View in: PubMed
    Score: 0.002
  84. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis. 2015 Apr 15; 60(8):1278-80.
    View in: PubMed
    Score: 0.002
  85. Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):530-7.
    View in: PubMed
    Score: 0.002
  86. Characteristics of males infected with common Neisseria gonorrhoeae sequence types in the Gonococcal Isolate Surveillance Project, San Francisco, California, 2009. Am J Epidemiol. 2013 Oct 15; 178(8):1289-95.
    View in: PubMed
    Score: 0.001
  87. The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection. Sex Transm Dis. 2013 May; 40(5):366-71.
    View in: PubMed
    Score: 0.001
  88. Using HIV testing history to measure the success of HIV partner services. Sex Transm Dis. 2013 May; 40(5):419-21.
    View in: PubMed
    Score: 0.001
  89. Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav. 2012 Jul; 16(5):1243-59.
    View in: PubMed
    Score: 0.001
  90. Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men--San Francisco, 2010. Sex Transm Dis. 2012 Jun; 39(6):482-4.
    View in: PubMed
    Score: 0.001
  91. Ending a failed intervention: STD performance measures. Sex Transm Dis. 2011 Sep; 38(9):887.
    View in: PubMed
    Score: 0.001
  92. Repeat syphilis among men who have sex with men--San Diego County, 2004-2009. Sex Transm Dis. 2011 Apr; 38(4):349-52.
    View in: PubMed
    Score: 0.001
  93. Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009. Sex Transm Dis. 2011 Feb; 38(2):127-9.
    View in: PubMed
    Score: 0.001
  94. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):537-43.
    View in: PubMed
    Score: 0.001
  95. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health. 2009 Jan 14; 9:17.
    View in: PubMed
    Score: 0.001
  96. Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose:ceramide galactosyltransferase gene. Genomics. 1996 Jul 01; 35(1):215-22.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.